NewGenIvf Group Limited Class A Ordinary Shares Market Cap ($2.15 Million)
Market Cap & Net Worth: NewGenIvf Group Limited Class A Ordinary Shares (NIVF)
NewGenIvf Group Limited Class A Ordinary Shares market cap. NewGenIvf Group Limited Class A Ordinary Shares (NASDAQ:NIVF) has a market capitalization of $2.15 Million ($2.15 Million) as of November 5, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #29956 globally and #6114 in its home market, demonstrating a -26.72% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NewGenIvf Group Limited Class A Ordinary Shares's stock price $0.85 by its total outstanding shares 3419922 (3.42 Million). Also see NIVF cash flow conversion for how efficiently the company converts equity into cash flow.
NewGenIvf Group Limited Class A Ordinary Shares Market Cap History (2024–2026)
NewGenIvf Group Limited Class A Ordinary Shares market cap history from 2024 to 2026. Data shows change from $1.43 Million to $2.91 Million (-59.95% CAGR). Check NIVF share price today for real-time trading data and today's change.
Index Memberships
NewGenIvf Group Limited Class A Ordinary Shares is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.61 Trillion | 0.00% | #865 of 976 |
Weight: NewGenIvf Group Limited Class A Ordinary Shares's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
NewGenIvf Group Limited Class A Ordinary Shares Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NewGenIvf Group Limited Class A Ordinary Shares's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore NewGenIvf Group Limited Class A Ordinary equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.50x
NewGenIvf Group Limited Class A Ordinary Shares's market cap is 0.50 times its annual revenue
Latest Price to Earnings (P/E) Ratio
0.24x
NewGenIvf Group Limited Class A Ordinary Shares's market cap is 0.24 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2024 | $1.43 Million | $5.43 Million | -$525.00K | 0.26x | N/A |
| 2025 | $2.36 Million | $4.73 Million | $9.88 Million | 0.50x | 0.24x |
Competitor Companies of NIVF by Market Capitalization
Companies near NewGenIvf Group Limited Class A Ordinary Shares in the global market cap rankings as of November 5, 2026. Also see NewGenIvf Group Limited Class A Ordinary total assets for a full breakdown of the balance sheet.
Key companies related to NewGenIvf Group Limited Class A Ordinary Shares by market ranking:
- HCA Healthcare, Inc. (NYSE:HCA): Ranked #283 globally with a market cap of $91.34 Billion USD.
- Fresenius SE & Co. KGaA (XETRA:FRE): Ranked #903 globally with a market cap of $29.19 Billion USD ( €24.97 Billion EUR).
- FRESENIUS SE+CO. ADR 1/4 (F:FREA): Ranked #985 globally with a market cap of $26.87 Billion USD ( €22.98 Billion EUR).
- Tenet Healthcare Corporation (NYSE:THC): Ranked #1213 globally with a market cap of $20.93 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #283 | HCA Healthcare, Inc. | NYSE:HCA | $91.34 Billion | $462.86 |
| #903 | Fresenius SE & Co. KGaA | XETRA:FRE | $29.19 Billion | €48.81 |
| #985 | FRESENIUS SE+CO. ADR 1/4 | F:FREA | $26.87 Billion | €10.20 |
| #1213 | Tenet Healthcare Corporation | NYSE:THC | $20.93 Billion | $266.69 |
Market Capitalization of NewGenIvf Group Limited Class A Ordinary Shares (2024–2026)
Market capitalization of NewGenIvf Group Limited Class A Ordinary Shares from 2024 to today. Between 2024 and today, NewGenIvf Group Limited Class A Ordinary Shares's market cap moved from $1.43 Million to $ 2.91 Million, with a yearly change of -59.95%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $2.91 Million | +23.19% |
| 2025 | $2.36 Million | +65.35% |
| 2024 | $1.43 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 4th, 2026 the market cap of NewGenIvf Group Limited Class A Ordinary Shares was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.15 Million USD |
| MoneyControl | $2.15 Million USD |
| MarketWatch | $2.15 Million USD |
| marketcap.company | $2.15 Million USD |
| Reuters | $2.15 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About NewGenIvf Group Limited Class A Ordinary Shares
NewGenIvf Group Limited, an investment holding company, provides an assisted reproductive service that helps couples and individuals for fertility treatments in Thailand, Cambodia, Hong Kong, and Kyrgyzstan. The company provides a range of fertility treatment solutions, including in vitro fertilization (IVF), ICSI, embryo culture, hormonal blood tests, infectious diseases tests, chromosome screen… Read more